Introduction
Modulating the expression of eukaryotic gene networks by small molecules is a challenge at the frontier of chemical biology. Pyrrole-imidazole polyamides are a class of cell-permeable small molecules that bind to the minor groove of DNA in a sequence-specifi c manner.
1,2 Sideby-side stacked N-methylpyrrole (Py) and N-methylimidazole (Im) carboxamides (Im/Py pairs) distinguish G•C from C•G base pairs, whereas Py/Py pairs specify for both T•A and A•T. 3 PyIm hairpin polyamides have been programmed for a broad repertoire of DNA sequences with affi nities similar to endogenous transcription factors. 4 They are cell permeable and infl uence gene transcription by disrupting protein-DNA interfaces. 2, 5, 6 Hairpin polyamide interference of DNA binding by transcription factors such as HIF-1α, 7 androgen receptor (AR), 8 and AP-1 9 has been described in recent years, yielding a new approach toward gene control by small molecules.
In parallel with our gene 1-5 targeted to the DNA sequence 5'-WGWWCW-3' and their ball-and-stick models. Ball-and-stick representation legend: black and white circles represent N-methylimidazole and N-methylpyrrole units, respectively, half-circle with -sign represents the terminal isophthalic acid substituent, and white half-diamond with + sign represents the triamine linker unit.
solid-phase protocols are characterized by low reaction yields due to ineffi cient macrocyclization. 10 We report here the solution-phase synthesis of cyclic polyamides 1-3 with an improved high-yield cyclization step. In addition, we examined the DNA binding properties of these compounds by thermal duplex DNA melting and performed preliminary studies of their in vitro ADMET properties.
Cyclic Py-Im polyamides 1-3 were shown to regulate endogenous gene expression in cell culture experiments.
Results and Discussion

Solution-Phase Synthesis of Cyclic Polyamides
Due to the symmetrical nature of cyclic polyamides 1-3 and their sequence similarity to previously described hairpin polyamide 4, 11 PyPyPy trimer 6 and Im-turn dimer 7 provide all the necessary atoms to synthesize 1-3. The preparation of advanced intermediates 6 and 7 has been detailed in the Chapter 2 (this thesis) 11 from readily available building blocks. 12 The cornerstone of our synthesis strategy capitalizes on the disparate physical properties of starting materials versus products, which permit purifi cation of most intermediates to be achieved by combinations of precipitation, trituration, and crystallization.
In addition, in situ deprotection of advanced pentafl uorophenyl ester polyamide 14 at high dilution leads to macrocyclization in high yield, affording cyclic polyamide 15.
The synthesis of tetramer-turn 9
begins with Im-turn dimer 7 (Scheme 3.1). 
Biological Assay for Cell Permeability
Hairpin polyamides have been shown to modulate endogenous gene expression in living cells by disrupting transcription factor-DNA binding in gene promoters. 2, [7] [8] [9] Recently, hairpin polyamide 4 was shown to inhibit androgen receptor-mediated expression of prostate-specifi c antigen (PSA) in LNCaP cells by targeting the DNA sequence 5´-AGAACA-3´ found in the ARE. 5g We utilized this cell culture transcription assay to investigate the biological activity of cyclic polyamides 1-3 in comparison to hairpin polyamides 4 and 5. Since small structural changes to polyamides have been shown to correlate with differences in cellular uptake properties, 5 it was not obvious whether cyclic polyamides 1-3 would permeate cell membranes and exhibit biological activity comparable to that of hairpin polyamides 4 and 5. Quantitative real-time RT-PCR analysis of DHT-induced PSA expression revealed that cyclic polyamides 1-3 all decreased PSA mRNA levels in LNCaP cells, with cycle 1 exhibiting activity comparable to that of acetylated hairpin polyamide 5 ( Figure   3 .2). On the basis of these results, we can infer that this class of cyclic Py-Im polyamides are cell permeable and can regulate endogenous gene expression in cell culture.
ADMET Studies of Polyamides 1 and 5
Due to the promising cell culture results obtained with cyclic polyamide 1 and hairpin polyamide 5 against PSA gene expression, we contracted preclinical in vitro absorption, distribution, metabolism, excretion, and toxicity (ADMET) 17 studies for both compounds.
> 100 μM).
Conclusion
We describe a solution-phase synthesis methodology for preparing cyclic Py-Im polyamides, highlighted by an effi cient macrocyclization between the alkyl linker amine and a pentafl uorophenol ester-activated amino acid. The three cyclic Py-Im polyamides possessed high DNA-binding affi nities and were capable of accessing the nucleus in cell culture, as judged by their ability to downregulate AR-activated PSA expression in cell culture. Preclinical ADMET analysis of cyclic polyamide 1 and hairpin polyamide 5 revealed favorable drug-like properties such as high liver stability and low toxicity. Ongoing work is focused on characterizing the precise molecular interactions between cyclic polyamides and their cognate DNA sequences by high-resolution crystallographic studies.
Experimental Section
General
Chemicals and solvents were purchased from Sigma-Aldrich and were used without further purifi cation. (R)-3,4-Cbz-Dbu(Boc)-OH was purchased from Senn Chemicals AG (code number 44159). All DNA oligomers were purchased HPLC purifi ed from Integrated DNA Technologies.
Water (18 MΩ) was purifi ed using a Millipore Milli-Q purifi cation system. Centrifugation was performed in a Beckman Coulter benchtop centrifuge (Allegra 21R) equipped with a Beckman swing-out rotor (model S4180 
UV Absorption Spectrophotometry
Melting temperature analysis was performed on a Varian Cary 100 spectrophotometer equipped with a thermo-controlled cell holder possessing a cell path length of 1 cm. A degassed aqueous solution of 10 mM sodium cacodylate, 10 mM KCl, 10 mM MgCl 2 , and 5 mM CaCl 2 at pH 7.0 was used as analysis buffer. DNA duplexes and polyamides were mixed in 1:1 stoichiometry to a fi nal concentration of 2 μM for each experiment. Prior to analysis, samples were heated to 90
°C and cooled to a starting temperature of 23 °C with a heating rate of 5 °C/min for each ramp.
Denaturation profi les were recorded at λ = 260 nm from 23 to 90 °C with a heating rate of 0.5 °C/ min. The reported melting temperatures were defi ned as the maximum of the fi rst derivative of the denaturation profi le.
Measurement of Androgen-Induced PSA mRNA
Experiments were performed as described previously 8 with the following modifi cations: (1) all compounds and controls were prepared in neat DMSO and then diluted with media to a fi nal concentration of 0.1% DMSO, and (2) mRNA was isolated with the RNEasy 96 kit (Qiagen, Valencia, CA).
BocHN-(R) β-CbzHN γ-Im-CO 2 H (8)
A solution of BocHN-(R) β-CbzHN γ-Im-CO 2 Et 7 (450 mg, 0.894 mmol) dissolved in MeOH (1.0 mL) and aqueous KOH (1 N, 2.0 mL, 2.0 mmol) was stirred at 37 ºC for 2 h. The reaction mixture was added to a cooled (ice bath) solution of distilled H 2 O (10 mL) preacidifi ed with aqueous HCl (1 N, 2.0 mL, 2.0 mmol), yielding a precipitate that was isolated by centrifugation (~4500 rpm C NMR: δ 167. 6, 160.0, 155.8, 155.4, 137.11, 137.09, 131.6, 128.2, 127.66, 127.55, 114.6, 77.7, 65.1, 48.7, 43.5, 38.0, 35.4, 28 8, 160.8, 158.5, 158.4, 155.84, 155.81, 155.5, 137.1, 136.0, 134.0, 128.3, 127.7, 127.6, 123.06, 123.00, 122.5, 122.2, 121.2, 120.7, 118.7, 118.6, 118.5, 114.0, 108.4, 104.9, 77.8, 65.2, 50.9, 48.8, 43.6, 38.2, 36.20, 36.18, 36. 
HCl•H2N-(R) β-CbzHN γ-ImPyPyPy-CO 2 Me (10)
A solution of BocHN-(R) β-CbzHN γ-ImPyPyPy-CO 2 Me 9 (125 g, 0.146 mmol) in anhydrous HCl in 1,4-dioxane (4.0 M, 10 mL) was stirred at 23 ºC for 2 h. The mixture was then diluted with 100 mL of anhydrous Et 2 O and fi ltered over a sintered glass funnel. C NMR: δ 167. 8, 162.0, 158.44, 158.38, 155.80, 155.77, 155.4, 137.1, 136.0, 133.9, 128.3, 127.7, 127.6, 123.0, 122.7, 122.6, 122.2, 121.2, 120.2, 119.5, 118.6, 118.5, 114.0, 108.4, 104.87, 104.83, 77.7, 65.1, 48.8, 43.5, 38.2, 36.2, 36.13, 36.06, 34.9, 28 
BocHN-(R) β-CbzHN γ-ImPyPyPy-(R) β-CbzHN γ-ImPyPyPy-CO 2 Me (12)
A 8, 161.6, 160.8, 158.5, 158.44, 158.42, 155.8, 155.6, 155.5, 137.1, 136.0, 134.00, 133.98, 128.3, 127.7, 127.63, 127.60, 123.11, 123.07, 123.00, 122.80, 122.77, 122.5, 122.3, 122.2, 122.1, 121.3, 120.8, 118.69, 118.66, 118.62, 118.52, 118.0, 114.1, 108.4, 104.9, 104.8, 104.5, 77.8, 65.21, 65.16, 50.9, 48.83, 48.78, 43.6, 42.2, 38. 
BocHN-(R) β-CbzHN γ-ImPyPyPy-(R) β-CbzHN γ-ImPyPyPy-CO 2 H (13)
A 94, 167.87, 162.4, 162.0, 161.6, 158.54, 158.50, 158.43, 155.8, 155.75, 155.74, 155.6, 155.5, 137.1, 136.0, 133.91, 133.90, 128.3, 127.7, 127.60, 127.57, 123.10, 123.07, 122.8, 122.7, 122.6, 122.3, 122.24, 122.17, 121.16, 121.15, 120.3, 119.5, 118.64, 118.61, 118.5, 118.0, 114.10, 114.06, 108.5, 105.0, 104.5, 77.8, 65.2, 65.1, 48.8, 43.6, 42.2, 38.4, 38.2, 36.2, 36.14, 36.10, 36.08, 36.0, 35.8, 34.9, 28 
cyclo-(-ImPyPyPy-(R) β-H2N γ-ImPyPyPy-(R) β-H2N γ-) (1)
A solution of BocHN-(R) β-CbzHN γ-ImPyPyPy-(R) β-CbzHN γ-ImPyPyPy-CO 2 Pfp 14 (84 mg, 0.049 mmol) in anhydrous CF 3 CO 2 H:CH 2 Cl 2 (1:1, 4 mL) was stirred at 23 ºC for 10 min prior to being concentrated to dryness in a 500 mL round-bottom fl ask. The residue was then dissolved in cold (0 ºC) DMF (10 mL), followed by immediate dilution with MeCN (300 mL) and DIEA (1.6 mL). The 
cyclo-(-ImPyPyPy-(R)
β-AcHN 
γ-ImPyPyPy-(R) β-H2N γ-) (3) and cyclo-(-ImPyPyPy-(R)
β-AcHN γ- ImPyPyPy-(R) β-AcHN γ-) (2) A solution of cyclo-(-ImPyPyPy-(R) β-H 2 N γ-ImPyPyPy-(R) β-H 2 N γ-) 1 (2.81
ImPyPyPy-(R) β-H2N γ-ImPyPyPy-(+)-IPA (4)
Prepared as described in Chapter 2 of this thesis. (Table 3 .2-3.7) are summaries of the ADMET results taken directly from the fi nal report provided by Apredica. The full ADMET report, which includes experimental conditions, can be found in Appendix B of this thesis. 
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